The phrase "availability of a true" is not correct and does not convey a clear meaning in written English.
It may be intended to refer to the existence or accessibility of something that is genuine or accurate, but the phrasing is awkward and unclear.
Example: "The availability of a true solution to the problem is essential for our success."
Alternatives: "access to a genuine" or "existence of an authentic".
The availability of a true artificial pancreas by means of a closed-loop system, linking continuous glucose monitoring with insulin-pump technology, would also constitute a significant advance, but major technological problems still need to be overcome.
The radiochemical performance of DATATOC highlights the potential of DATA-conjugates to carry 68Ga-PET into widespread application through the availability of a true 'kit-type' formulation, a facile and cost effective synthesis as well as the preparation of previously inaccessible radiotracers.
Quality and efficiency of both institutional and home-care should be guaranteed in order to avoid undesirable situations (e.g. unacceptably long waiting lists), which could undermine the availability of a true choice once the demand for care becomes urgent (Larsson 2007).
Or, to put the point the other way round, if we don't think that linguistically-based reasons such as the availability of an (apparently) true quantified sentence like (14) commit us to bizarre entities like Nappy, we should not think that such reasons commit us to fictional entities either.
Nevertheless, there are ongoing debates about the definition of 'true' EPC, as well as the availability of a reliable method to assess their quantity and quality, functional status, and therapeutic application.
Furthermore, differences in rates over time could be due to improved case detection, increased public awareness leading to earlier detection and wider availability of treatment services, instead of a true increase in occurrence [ 1, 2].
The advantage of using a simulated data set in the example analysis is the availability of the true genetic values of the individuals, enabling us to determine the accuracy of the estimates by a direct comparison of the simulated and estimated genetic values.
However, availability of the true tumor specific target genes and appropriate interpretation of both positive and negative results still remains a significant challenge and a concern.
Two groups of clinics have to be distinguished according to the availability of the true number of IS cases, i.e. those hospitals included in the sample where the true reporting quota is available and the hospitals not in the sample where this is not the case.
However, this situation requires the availability of a reference method or data sets, in order to count true and false positives, as well as true and false negatives.
1 This number has increased annually for more than two decades, probably because of a combination of a true increase in prevalence, more widespread screening, the availability of more sensitive tests, and more complete national reporting.
